Colorado-based Biodesix, a company that creates technology around lung cancer, announced that it has acquired Seattle’s Integrated Diagnostics for an undisclosed sum. Integrated Diagnostics, also known as Indi, develops a… Read More
A liquid biopsy sounds like far-future tech: It’s essentially a blood test that can detect cancer by analyzing DNA from dead tumor cells that floats in a patient’s bloodstream. These… Read More
University of Washington spinout Bellwether Bio isn’t disclosing much about its technology, but what it is sharing could be promising news for cancer patients and Seattle biotech alike. The startup,… Read More